Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth factors and integrins represent two major classes of cell surface receptors that cooperatively regulate fundamental cellular processes through bidirectional crosstalk. Growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor-beta (TGF-beta), typically signal through receptor tyrosine kinases (RTKs) to drive cell proliferation, differentiation, and survival (Ivaska & Heino, 2011, Nature Reviews Molecular Cell Biology). Integrins are heterodimeric transmembrane receptors that mediate cell-extracellular matrix (ECM) adhesion, providing the structural context necessary for growth factor signaling to occur efficiently. This synergy is often exploited in pathological states; for instance, integrins can physically associate with growth factor receptors to amplify oncogenic signaling, promoting tumor invasion and metastasis (Desgrosellier & Cheresh, 2010, Nature Reviews Cancer). In fibrosis, integrins like alpha-v-beta-6 are essential for the activation of latent TGF-beta, a master regulator of collagen deposition (Henderson & Sheppard, 2013, Nature). Therapeutic interventions targeting this axis include monoclonal antibodies that neutralize growth factor ligands or block specific integrin subunits to disrupt the pro-survival and pro-migratory environment of diseased tissues.
Inhibition of ligand binding to growth factor receptors or integrins, disruption of receptor-integrin physical association, and blockade of downstream intracellular signaling cascades such as the MAPK/ERK and PI3K/AKT pathways.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Factors and Integrins (GF-Integrin Crosstalk).